GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 24 filers reported holding GAIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,594 | -29.6% | 27,925 | -3.8% | 0.00% | – |
| Q2 2023 | $130,027 | +8.9% | 29,024 | +17.1% | 0.00% | – |
| Q1 2023 | $119,430 | +52.7% | 24,778 | -0.8% | 0.00% | – |
| Q4 2022 | $78,188 | +4.3% | 24,980 | +9.1% | 0.00% | – |
| Q3 2022 | $75,000 | -11.8% | 22,901 | -2.7% | 0.00% | – |
| Q2 2022 | $85,000 | +97.7% | 23,541 | +121.3% | 0.00% | – |
| Q1 2022 | $43,000 | -28.3% | 10,637 | -4.7% | 0.00% | – |
| Q4 2021 | $60,000 | -29.4% | 11,159 | -2.8% | 0.00% | – |
| Q3 2021 | $85,000 | -26.7% | 11,476 | -1.6% | 0.00% | – |
| Q2 2021 | $116,000 | – | 11,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
| CM Management, LLC | 90,000 | $489,000 | 0.37% |
| Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
| Veritable, L.P. | 25,064 | $136,000 | 0.00% |
| Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
| MORGAN STANLEY | 800 | $4,000 | 0.00% |